Dr. JeanMarie Guenot Is Helping Patients Fight Disease Through Treatment Development

JeanMarie Guenot Ph.D.is the CEO and President fo Amphivena Therapeutics Inc. Under her highly skilled leadership the company develops a variety of treatment products for diseases. The company is growing and developing new treatments quickly to help individuals overcome their medical issues. She has vast experience in a variety of fields withing the healthcare and pharmaceutical industry. Jeanmarie Guenot specializes in rebuilding and restructuring businesses as well as project alliance, venture capital, and drug development. Amphivena Therapeutics specializes in bifunctional antibody therapies for malignant cancer related to the blood.

Dr. JeanMarie Guenot has an impressive resume to add to her vast skills and insight. She founded SKS Ocular prior to working for Amphivena. Her company specialized in glaucoma and macular degeneration therapy as well as ocular drug delivery technologies. Some of her other notable work with companies includes Hoffmann-LaRoch as a business advisor. Sh worked for PDL BioPharma as the VP of Corporate and Business Development. During her time with those companies, Guenot oversaw strategic collaboration for developing cancer treatment drugs, investing, business development, licensing, acquisitions, and alliance management. She worked within the areas of neurology, ophthalmic disease, cardiovascular disease, and oncology.

Her first job in the field she has worked in for decades was at Atlas Venture. She specialized in creating life science companies as well as managing investments at https://www.crunchbase.com/person/jeanmarie-guenot. She also opened her own company called Guenot LLC shortly after beginning her career in the field. She also worked as a scientist at many of the to facilities in the country. She helped to develop treatment drugs for a variety of disease for both autoimmune disorders as well as for cancer. Dr. Guetnot attended The Wharton School in Pennsylvania where she earned her MBA. She later attended the Univesity of California where she was able to obtain her Ph.D. She specializes in medicinal and physical chemistry as well as quantum mechanical molecular dynamic and drug design.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies